// App-Quantinova.ai

P318 : Clinical Outcomes in Immunotherapy Induced Pneumonitis

Researchers

Presenter

  • A. E. Davis

Principal Investigators

  • D. B. Johnson

  • J. A. Bastarache

Medical Centers

  • Internal Medicine Residency Program, Vanderbilt University Medical Center, Nashville, TN, United States

  • Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, United States

  • Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary alveolar proteinosis

  • Dyspnea

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved